The post Crypto Market Sentiment Not Fearful Enough For Bottom: Santiment appeared on BitcoinEthereumNews.com. Crypto traders have not yet shown enough fear on The post Crypto Market Sentiment Not Fearful Enough For Bottom: Santiment appeared on BitcoinEthereumNews.com. Crypto traders have not yet shown enough fear on

Crypto Market Sentiment Not Fearful Enough For Bottom: Santiment

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Crypto traders have not yet shown enough fear on social media to confirm a market bottom, according to a crypto analyst who suggested Bitcoin could still slide to around $75,000.

“It looks very tempting to come even closer to it,” crypto market sentiment platform Santiment founder, Maksim Balashevich, said on a video published to YouTube on Friday.

A move to that level would represent an approximate 14.77% drop from Bitcoin’s (BTC) current price of $88,350, according to CoinMarketCap.

Bitcoin is up 1.81% over the past 30 days. Source: CoinMarketCap

Balashevich explained that his hesitation comes from observing significant optimism online that the downtrend will reverse in the near term, which he said is not usually the case when a true market bottom is forming.

“The crowd isn’t scared enough for a bottom,” Santiment said in a report on the same day.

Overly optimistic comments are “not what I want to see,” says Balashevich

“In one particular crowd-dominated or retail-dominated channel, they’re mostly discussing Bank of Japan cut rates, and bears got caught, and now we’ll continue up from here,” he said.

“These kinds of statements are not what I want to see,” he said, adding that if the circumstances were different, he would be “very confident” in calling a market bottom.

Japan’s central bank pushed interest rates to a 30-year high of 0.75% on Friday, a move that has previously been associated with roughly 20% corrections in Bitcoin.

However, Balashevich said a move down to this price level would potentially provide a “very good setup” for traders.

On Thursday, Jurrien Timmer, Fidelity’s director of global macro research, said that Bitcoin could take a “year off” in 2026, with the price potentially falling to around $65,000.

Other analysts, such as Bitwise chief investment officer Matt Hougan, are forecasting 2026 to be an “up year” for Bitcoin.

Crypto market indicators conflict with Balashevich’s outlook

While Balashevich is not convinced that the market has yet reached its bottom, crypto market indicators suggest otherwise.

The Crypto Fear & Greed Index, which measures overall crypto market sentiment, has been lingering in “Extreme Fear” territory since Dec. 14. On Sunday, the Index posted an “Extreme Fear” score of 20.

Related: Bitcoin institutional buys flip new supply for the first time in 6 weeks

Other indicators are suggesting risk-off positioning among crypto traders. 

The Altcoin Season Index, which measures the performance of the top 100 altcoins relative to Bitcoin over the past 90 days, posted a “Bitcoin Season” reading of 17 out of 100 on Saturday.

Magazine: Big questions: Would Bitcoin survive a 10-year power outage?

Source: https://cointelegraph.com/news/crypto-market-sentiment-fear-levels-bitcoin-price-slide-santiment?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09